Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/1995
11/02/1995WO1995028948A1 Compositions comprising dna damaging agents and p53
11/02/1995WO1995028943A1 USE OF SPIRAMYCIN FOR TREATING GASTROINTESTINAL DISORDERS CAUSED BY $i(H. PYLORI)
11/02/1995WO1995028941A1 Composition and method for treatment of cmv infection
11/02/1995WO1995028940A1 Methods for inhibiting human immunodeficiency virus
11/02/1995WO1995028938A1 Molten granulated sucralfate preparation and process for producing the same
11/02/1995WO1995028936A1 Use of bisphophonates for inhibiting bone resorption following implantation of orthopedic prosthesis
11/02/1995WO1995028935A1 Pharmaceutical formulations containing a beta-lactamase inhibiting penem in combination with a beta-lactam antibiotic and their use in the treatment of bacterial infections
11/02/1995WO1995028934A2 Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
11/02/1995WO1995028933A1 Use of arylpiperazine derivatives for the treatment of parkinson's disease and psychosis
11/02/1995WO1995028932A1 Transdermal delivery of alpha adrenoceptor blocking agents
11/02/1995WO1995028931A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995WO1995028930A1 Dosage forms and method for ameliorating male erectile dysfunction
11/02/1995WO1995028929A1 Aminoline-n-oxide antimicrobials for use against h. pylori infections
11/02/1995WO1995028928A1 17β-ARYL-4-AZA-STEROID DERIVATIVES
11/02/1995WO1995028927A1 Polymer coated tablet comprising amoxycillin and clavulanate
11/02/1995WO1995028926A1 Pde iv inhibitors for treating multiple sclerosis
11/02/1995WO1995028925A1 Disease preventive/remedy
11/02/1995WO1995028924A1 COMBINED PREPARATIONS CONTAINING A p-OXYBENZOIC ACID DERIVATIVE SUCH AS LIFIBROL AND AN HMG-CoA-REDUCTASE INHIBITOR SUCH AS LOVASTATIN, PRAVASTATIN OR SIMVASTATIN
11/02/1995WO1995028923A1 Taxane class derivative based pharmaceutical compositions
11/02/1995WO1995028922A1 Use of benzylidene-malononitrile derivates for the treatment of leukemia
11/02/1995WO1995028921A1 Ecadotril as a renal protective agent
11/02/1995WO1995028919A1 MEDICAMENT CONTAINING p-OXYBENZOIC ACID DERIVATIVE AND FIBRATE
11/02/1995WO1995028918A1 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating
11/02/1995WO1995028917A1 Once-a-day metoprolol oral dosage form
11/02/1995WO1995028915A1 Red blood cell surrogate
11/02/1995WO1995028838A1 Modified amino acids for drug delivery
11/02/1995EP0679657A2 Nucleosides and oligonucleotides containing 2'-ether groups
11/02/1995EP0679656A1 Improvements in platinum complexes
11/02/1995EP0679645A1 Pharmacologically active CNS pyridmidin compounds
11/02/1995EP0679631A1 Biaromatic acetylated, an adamantyl group containing compounds, pharmaceutical and cosmetic compositions containing them and their use
11/02/1995EP0679630A1 Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses
11/02/1995EP0679628A1 Polyene derivatives, pharmaceutical and cosmetic composition containing them and their use
11/02/1995EP0679400A1 Oral dosage forms of azithromycin avoiding drugfood interaction
11/02/1995EP0679399A1 Phosphate diesters for treatment of epidermis proliferative diseases
11/02/1995EP0679398A1 Immunopotentiating and infection protective agent and production thereof
11/02/1995EP0679397A2 Use of substituted amines for the treatment of cerebral insufficiencies
11/02/1995EP0679396A1 Use of 3-substituted-2-oxidole-1-carboxamides for the manufacture of a medicament in the treatment and prevention of ischemia induced myocardial injury and cytokine mediated myocardial injury
11/02/1995EP0679395A1 Pharmaceutical compositions containing a ketoprofen solution in a soft gelatine capsule and method to produce them
11/02/1995EP0679394A2 Menatetronome derivative as antiarteriosclerotic agent
11/02/1995EP0679393A2 Pharmaceutical composition for treating osteoporosis containing xanthohumol
11/02/1995EP0679392A1 Pharmaceutical form for transdermal administration
11/02/1995EP0679388A1 Cosmetic and/or dermatologic skin depigmentation composition and its use
11/02/1995EP0679387A1 Cosmetic and/or dermatologic composition with a hydrophilic support and vitamin C for extemporaneously mixing
11/02/1995EP0679194A1 Method to predict active growth of bacteria adhered to a surface
11/02/1995EP0679189A1 Cloning of enterokinase and method of use
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0679161A1 Thiazolidine derivatives, preparation thereof and drugs containing same
11/02/1995EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/02/1995EP0679157A1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
11/02/1995EP0679156A1 Process for the preparation of 10-desacetoxybaccatin iii
11/02/1995EP0679154A1 New crystalline form of a vitamin d analogue.
11/02/1995EP0679153A1 Amino acids and peptides having modified terminals
11/02/1995EP0679086A1 Potentiation of temozolomide in human tumour cells
11/02/1995EP0679085A1 Chemical compounds, their preparation and use
11/02/1995EP0679084A1 Hydantoin and succinimide-substituted derivatives of spiroindanylcamphorsulfonyl oxytocin antagonists
11/02/1995EP0679083A1 Prevention and treatment of sepsis
11/02/1995EP0679082A1 C10 taxane derivatives and pharmaceutical compositions
11/02/1995EP0679081A1 Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
11/02/1995EP0679080A1 L-arginine and analogues as thrombocyte aggregation inhibitors
11/02/1995EP0679057A1 Structured lipids
11/02/1995EP0665750A4 Benzo-fused lactams promote release of growth hormone.
11/02/1995EP0619809B1 Process for preparing flunixin and intermediates thereof
11/02/1995EP0561766B1 Use of essential fatty acids for the preparation of a drug for the treatment of eczema
11/02/1995EP0552176B1 Quaternary ammonium salts derived from chitosan
11/02/1995EP0491956B1 Reveromycin a, production thereof, and antitumor drug and fungicide
11/02/1995EP0471841B1 Sulfonamide derivative and pharmaceutical composition containing the same
11/02/1995EP0172880B2 Use of long chain and medium chain triglycerides
11/02/1995DE4415204A1 Compsns contg retinyl salicylate or acetyl-salicylate
11/02/1995DE4414538A1 Präparate zur Therapie der kombinierten Hyperlipidämie mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem Fibrat Preparations for the treatment of combined hyperlipidemia containing a p-Oxybenzoesäurederivat and a fibrate
11/02/1995DE4414537A1 Kombinationspräparate mit einem Gehalt an einem p-Oxybenzoesäurederivat und einem HMG-CoA-Reduktase-Hemmer Combination products containing a p-Oxybenzoesäurederivat and an HMG-CoA reductase inhibitors
11/02/1995DE4414502A1 Ointments for treating painful conditions
11/02/1995DE19515401A1 [1,3-·1··4·C¶2¶]-Glycerin-nitrate und Verfahren zu deren Herstellung sowie diese enthaltende Lösungen [1,3 ·· · 1 · 4 C¶2¶] -glycerol-nitrate and methods for their preparation and to solutions containing
11/02/1995CA2533837A1 Cephalosporin synthesis
11/02/1995CA2193838A1 Disease preventive/remedy
11/02/1995CA2188784A1 O-acyl-4-phenyl-cycloalkanols, their salts, medicaments containing such compounds, and their use, as well as a method of preparing them
11/02/1995CA2188748A1 Benzocycloalkylazolethione derivatives
11/02/1995CA2188697A1 Use of spiramycin for treating gastrointestinal disorders caused by h. pylori
11/02/1995CA2188682A1 Method for stabilizing compound dx-52-1 and lyophilized composition thereof
11/02/1995CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995CA2188496A1 Polymer coated tablet comprising amoxycillin and clavulanate
11/02/1995CA2188467A1 Modified amino acids for drug delivery
11/02/1995CA2188320A1 Compositions and methods for cell transformation
11/02/1995CA2188269A1 Pde iv inhibitors for treating multiple sclerosis
11/02/1995CA2188034A1 17.beta.-aryl-4-aza-steroid derivatives
11/02/1995CA2188031A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995CA2187932A1 Substituted sulfonamides as selective .beta.3 agonists for the treatment of diabetes and obesity
11/02/1995CA2187928A1 Substituted 5,6-dihydro-5-oxo-1,4-dithiino-(2,3-d)-pyridazine-2,3-dicarbonitriles, compositions containing them and their use as antimicrobials
11/02/1995CA2187752A1 Use of benzylidene-malononitrile derivates for the treatment of leukemia
11/02/1995CA2187323A1 A ranitidine tablet having a hydroxypropylmethylcellulose containing coating and a method for producing said coating
11/02/1995CA2177066A1 Red blood cell surrogate
11/01/1995CN1110968A Substituted N-piperidino-pyrazole-3-carboxamide
11/01/1995CN1110918A 复方胡萝卜素胶囊 Compound Carotene Capsules
11/01/1995CN1110914A Compound capsule for fever release pain stop and anti-inflammation
11/01/1995CN1110913A Pharmaceutical composition
11/01/1995CN1110912A Method for improving performance of tablet and granular medicines
11/01/1995CN1030196C Positive inotropic and lusitropic 3,5-dihydro-imidazo |2,1-6¨ quinazolin-2(1H)-one derivatives
11/01/1995CN1030195C Hypoglycemic thiazolidinediones and intermediates
10/1995
10/31/1995US5463181 Farnesyl: protein transferase inhibitors as anticancer agents
10/31/1995US5463152 Halofluorocarbon hydrogenolysis
10/31/1995US5463122 Arylthio compounds
1 ... 6971 6972 6973 6974 6975 6976 6977 6978 6979 6980 6981 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 ... 7860